Zepbound 12.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FA0Q4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $32,774
Award facts
- Contract value 100% obligated
- $32,773.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on December 22, 2025, by the Defense Logistics Agency (DLA) for the supply of Zepbound 12.5 mg/0.5 mL pens with a ceiling value of $32,773.68. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of December 23, 2025, and was competitively awarded with no set-aside designation. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems.
The award reflects AmerisourceBergen's critical role as a pharmaceutical prime vendor to the federal government, particularly supporting the Defense Health Agency and other military medical supply chain requirements. Zepbound, a diabetes and weight-management medication, represents the type of specialty pharmaceutical products that the company routinely delivers across its expansive federal contract portfolio. The DLA Troop Support Medical contract enables AmerisourceBergen to supply an extensive range of medications, vaccines, and medical supplies to support military healthcare programs worldwide, demonstrating the company's capacity to fulfill diverse medical procurement needs through competitive federal contracting.
Quick answers
Who was awarded contract SPE2DR26FA0Q4?
SPE2DR26FA0Q4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 22, 2025.
How much is contract SPE2DR26FA0Q4 worth?
The government has obligated $32,774 on SPE2DR26FA0Q4.
Is contract SPE2DR26FA0Q4 an order under another contract?
Yes. SPE2DR26FA0Q4 is a delivery order under SPE2DR25D2014, an indefinite delivery contract.
Was contract SPE2DR26FA0Q4 competed?
The extent of competition for SPE2DR26FA0Q4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award